Edentree Asset Management »

Autolus Therapeutics Plc spon ads shares owned by Edentree Asset Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Edentree Asset Management from 13F filings

Historical chart of Edentree Asset Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Edentree Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Edentree Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $486k 300k 1.62
2025-06-30 $684k 300k 2.28
2025-03-31 $462k 300k 1.54
2023-06-30 $430k 180k 2.39

More positions owned by Edentree Asset Management

Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Medtronic SHS (MDT)
Xylem (XYL)
Nike CL B (NKE)
Merck & Co (MRK)
Palo Alto Networks (PANW)
Waste Connections (WCN)
Analog Devices (ADI)
Principal Financial (PFG)
salesforce (CRM)
Bruker Corporation (BRKR)
Msa Safety Inc equity (MSA)
Advanced Drain Sys Inc Del (WMS)
Avient Corp (AVNT)

View all positions for Edentree Asset Management

Top funds holding Autolus Therapeutics Plc spon ads

MAK Capital One
Blackstone Group
Syncona Portfolio
Armistice Capital
Polygon Management
Schroder Investment Management Group
Citadel Advisors
Renaissance Technologies
Frazier Life Sciences Management
BlackRock
AXA Investment Managers
Laurion Capital Management
Deep Track Capital
Acadian Asset Management
Affinity Asset Advisors

View all funds holding Autolus Therapeutics Plc spon ads